Brief: Bioxyne Joins Asian Partner & Sells 49% Of Direct Selling Business

BLS Pharmaceuticals

24/10/2022 24:18

Oct 24 (Reuters) - Bioxyne Ltd  BXN.AX :
    * JOINS ASIAN PARTNER & SELLS 49% OF DIRECT SELLING BUSINESS
    * SHARE PLACEMENT OF 25 MILLION SHARES AT A$0.04 EACH FOR
A$1
MILLION
    * SALE OF 49% INTEREST IN DIRECT SELLING GROUP OF COMPANIES
FOR
A$1 MILLION
    * CORE BUSINESS BEING WHOLESALE OF COMPANY'S PATENTED STRAIN
OF
PROBIOTICS, REMAINS UNCHANGED

Source text for Eikon:  ID:nASX9rsSJK 
Further company coverage:  BXN.AX